Begin main content

Alogliptin (Nesina) for Type 2 Diabetes Mellitus

Last Updated: January 30, 2014
Result type: Reports
Project Number: SR0368-000
Product Line: Common Drug Review

Generic Name: Alogliptin

Brand Name: Nesina

Manufacturer: Takeda Canada Inc.

Indications: Diabetes mellitus (Type 2)

Submission Type: New

Project Status: Complete

Date Recommendation Issued: January 15, 2015

Recommendation Type: Do not list

Tags

diabetes mellitus, type 2, diabetes